Table 2 Joinpoint analysis of cancer mortality for age-standardized rates for all ages and specific for age groups for both sexes. Sergipe, 1980–2018.
Age groups | JP | APC | 95% CI | AAPC | 95% CI |
|---|---|---|---|---|---|
Male | |||||
All | 2 | (1980–2000) 2.44a | 1.15; 3.74 | 2.98a | 1.55; 4.42 |
– | (2000–2005) 11.87a | 1.91; 22.80 | |||
– | (2005–2018) 0.56 | − 0.60; 1.74 | |||
0–19 | 1 | (1980–2000) 5.70a | 3.11; 8.35 | 2.79a | 1.17; 4.43 |
– | (2000–2018) − 0.35 | − 2.44; 1.78 | |||
20–44 | 0 | (1980–2018) 1.31a | 0.53; 2.10 | 1.31a | 0.53; 2.10 |
45–64 | 1 | (1980–2009) 3.63a | 2.78; 4.49 | 2.31a | 1.43; 3.21 |
– | (2009–2018) − 1.82 | − 4.48; 0.91 | |||
65+ | 2 | (1980–1998) 2.48a | 0.91; 4.06 | 4.29a | 3.08; 5.51 |
– | (1998–2005) 12.54a | 7.13; 18.21 | |||
– | (2005–2018) 2.56a | 1.51; 3.62 | |||
Female | |||||
All | 2 | (1980–1987) − 2.41 | − 7.82; 3.31 | 1.73a | 0.55; 2.93 |
– | (1987–2006) 4.26a | 3.24; 5.30 | |||
– | (2006–2018) 0.26 | − 0.89; 1.42 | |||
0–19 | 2 | (1980–1988) − 14.41a | − 21.48; − 6.70 | 1.28 | − 3.31; 6.09 |
– | (1988–1992) 46.66 | − 2.72; 121.09 | |||
– | (1992–2018) − 0.01 | − 1.02; 1.01 | |||
20–44 | 4 | (1980–1990) − 3.32 | − 7.58; 1.13 | 2.24 | − 3.91; 8.79 |
– | (1990–1993) 22.53 | − 27.45; 106.93 | |||
– | (1993–1997) − 11.93 | − 29.67; 10.28 | |||
– | (1997–2000) 21.58 | − 21.34; 87.90 | |||
– | (2000–2018) 0.25 | − 0.76; 1.28 | |||
45–64 | 2 | (1980–1990) − 0.68 | − 4.39; 3.18 | 2.13a | 0.57; 3.71 |
– | (1990–2006) 4.47a | 2.92; 6.06 | |||
– | (2006–2018) 0.57 | − 1.91; 0.78 | |||
65+ | 2 | (1980–2000) 1.94a | 0.76; 3.12 | 2.56a | 1.65; 3.48 |
– | (2000–2005) 10.81a | 1.81; 20.61 | |||
– | (2005–2018) 1.01 | − 0.04; 2.08 | |||
Ill-defined causes | |||||
Total | 2 | (1980–2002) − 4.22a | − 4.85; − 3.59 | − 7.07a | − 8.04; − 6.09 |
– | (2002–2006) − 34.85a | − 47.65; − 18.93 | |||
– | (2006–2018) 0.81 | − 2.69; 4.44 | |||